Phibro Animal Health grants RSUs to its COO

Miller Larry Lee reported acquisition or exercise transactions in this Form 4 filing.

The filer has since corrected this document, so the figures below are the ones originally reported and some of them may have changed. Read the amended Form 4/A for what the company says now.

Rhea-AI Filing Summary

Miller Larry Lee reported acquisition or exercise transactions in this Form 4 filing.

Phibro Animal Health Corp reported that Chief Operating Officer Larry Lee Miller received a grant of 3,522 restricted stock units (RSUs) representing Class A Common Stock on August 6, 2026. These RSUs vest in three substantially equal installments on the first three anniversaries of August 1, 2026, contingent on his continued employment. Following this award, Miller directly holds 38,071 shares of Class A Common Stock, including the RSUs.

Insider Trade Summary

Grant/Award: 3,522 shares

Grant/Award 1 txn

Insider Miller Larry Lee

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2	3,522	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 38,071 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

Key Figures

RSUs granted: 3,522 shares Shares following transaction: 38,071 shares Grant price per share: $0.00 per share +1 more

4 metrics

RSUs granted 3,522 shares Restricted stock units representing Class A Common Stock granted on 2026-08-06

Shares following transaction 38,071 shares Total Class A Common Stock held directly by Larry Lee Miller after the grant

Grant price per share $0.00 per share Compensation-related RSU award with no cash paid per share

Vesting schedule 3 installments over 3 years RSUs vest in substantially equal installments on first three anniversaries of August 1, 2026

Key Terms

restricted stock units ("RSUs"), contingent right, vest, substantially equal installments

4 terms

restricted stock units ("RSUs") financial

"The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"each of which represents a contingent right to receive one share of Class A Common Stock"

vest financial

"The RSUs vest in substantially equal installments on each of the first three anniversaries"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

substantially equal installments financial

"The RSUs vest in substantially equal installments on each of the first three anniversaries"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did PAHC grant to its COO Larry Lee Miller?

Phibro Animal Health Corp granted Larry Lee Miller 3,522 restricted stock units (RSUs) of Class A Common Stock. Each RSU represents a contingent right to one share, subject to vesting conditions tied to continued employment.

When do Larry Lee Miller’s new PAHC RSUs vest?

The 3,522 RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026. Vesting is conditioned on Miller’s continued employment through each applicable vesting date.

How many PAHC shares does Larry Lee Miller hold after this Form 4 transaction?

After the reported RSU grant, Larry Lee Miller holds 38,071 shares of Phibro Animal Health Corp Class A Common Stock. This total includes the 3,522 RSUs reported, which are subject to future vesting conditions.

Was the PAHC COO’s RSU grant a market purchase or a compensation award?

The transaction is reported with code A, described as a grant, award, or other acquisition. The per-share price is $0.00, indicating this is a compensation-related equity award rather than an open-market stock purchase.

Does this PAHC Form 4 involve any derivative security exercises or sales?

No, this Form 4 reports a single acquisition of 3,522 RSUs of Class A Common Stock. The filing shows no sales, option exercises, gifts, or derivative transactions associated with this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:18 PM Accepted by SEC EDGAR 08/10/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miller Larry Lee

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07059

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/06/2026		A		3,522(2)	A	$0	38,071	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

	/s/ Judith Weinstein, as Attorney-in-Fact for Larry Lee Miller	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)